Athyrium Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-14,600,444
| Closed | -$1.26M | – | 4 |
|
2023
Q3 | $1.26M | Hold |
14,600,444
| – | – | 1.11% | 6 |
|
2023
Q2 | $8.18M | Hold |
14,600,444
| – | – | 5.31% | 5 |
|
2023
Q1 | $16.6M | Hold |
14,600,444
| – | – | 5.96% | 4 |
|
2022
Q4 | $16.4M | Hold |
14,600,444
| – | – | 6.87% | 5 |
|
2022
Q3 | $30.7M | Buy |
14,600,444
+6,451,612
| +79% | +$13.5M | 11.48% | 4 |
|
2022
Q2 | $11.1M | Hold |
8,148,832
| – | – | 4.66% | 7 |
|
2022
Q1 | $13.8M | Hold |
8,148,832
| – | – | 4.9% | 6 |
|
2021
Q4 | $8.8M | Buy |
+8,148,832
| New | +$8.8M | 3.14% | 5 |
|